C. Tomolillo

发表

Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach.

G. Leoncini, G. Sacchi, F. Viazzi, 2002, Journal of hypertension.

Changes in Renal Resistive Index and Urinary Albumin Excretion in Hypertensive Patients under Long-Term Treatment with Lisinopril or Nifedipine GITS

G. Leoncini, F. Viazzi, M. Ravera, 2002, Nephron.

Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension

G. Leoncini, G. Sacchi, F. Viazzi, 2005, Journal of hypertension.

Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension.

G. Leoncini, F. Viazzi, E. Ratto, 2006, American journal of hypertension.

Pulse pressure and subclinical cardiovascular damage in primary hypertension.

G. Leoncini, F. Viazzi, M. Ravera, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Left ventricular geometry and function in patients with essential hypertension and microalbuminuria.

G. Leoncini, F. Viazzi, M. Ravera, 1999, Journal of hypertension.

Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised?

G. Leoncini, F. Viazzi, E. Ratto, 2006, American journal of hypertension.

Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography

G. Leoncini, F. Viazzi, M. Ravera, 2004, Journal of hypertension.

Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension.

G. Leoncini, F. Viazzi, D. Parodi, 2005, Journal of the American Society of Nephrology : JASN.

Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography

G. Leoncini, F. Viazzi, M. Ravera, 2004, Journal of Hypertension.

Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients

M. Vercelli, G. Leoncini, F. Viazzi, 2010, Journal of hypertension.

Renal and cardiac abnormalities in primary hypertension

G. Leoncini, F. Viazzi, C. Tomolillo, 2009, Journal of hypertension.

Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study.

M. Vercelli, G. Leoncini, F. Viazzi, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension.

M. Ravera, C. Tomolillo, R. Pontremoli, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria.

G. Leoncini, F. Viazzi, E. Ratto, 2006, Journal of the American Society of Nephrology : JASN.

Mild renal dysfunction and renal vascular resistance in primary hypertension.

G. Leoncini, F. Viazzi, D. Parodi, 2005, American journal of hypertension.

Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients

G. Leoncini, F. Viazzi, D. Parodi, 2005, Journal of internal medicine.

Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications.

G. Sacchi, F. Viazzi, M. Ravera, 1997, Hypertension.

Left ventricular geometry and function in patients with essential hypertension and microalbuminuria.

G. Leoncini, F. Viazzi, M. Ravera, 1998, Journal of hypertension.

Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension.

G. Sacchi, F. Viazzi, C. Tomolillo, 1997, Kidney international. Supplement.